Dark

SLNO
Soleno Therapeutics, Inc. Common Stock
stock NASDAQ

At Close

Jun 6, 2025 3:59:58 PM EDT

75.52USD+0.399%(+0.30)594,117

0.00Bid 0.00Ask 0.00Spread

Pre-market

0.00USD-100.000%(-75.22)0

After-hours

Jun 6, 2025 4:00:30 PM EDT

75.51USD-0.093%(-0.07)3,601

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

3.81B

CEO

Anish Bhatnagar

Headquarters

Redwood City, California, USA

Industry

Biotechnology

Last Split

Aug 26, 20221for15reverse

NEOG CEMI NYMX NTRP XLV

SLNO Stats

Avg. Vol. 10 Day

672,206

Avg. Vol. 30 Day

740,336

Employees

Market Cap

3,808,773,305

Shares Out.

50,393,931

On/Off Exchange

53%/47%

6 Month Beta

0.88

1 Year Beta

0.99

2 Year Beta

-0.38

3 Year Beta

0.13

52 Week Low

36.93

52 Week High

80.99

SMA50

72.76

SMA200

55.50

1 Week

+3.04%

1 Month

+1.23%

3 Month

+68.78%

6 Month

+53.77%

1 Year

+65.89%

2 Year

+1,216.73%

5 Year

+55.51%

Profile

soleno therapeutics, inc. is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. the company is currently advancing its lead candidate, dccr, a once-daily oral tablet for the treatment of pws, into a phase iii clinical development program in early 2018.

SLNO Stock Summary

Soleno Therapeutics, Inc. Common Stock (NASDAQ:SLNO) stock price today is $75.52, and today's volume is 594,117. SLNO is up 0.399% today. The 30 day average volume is 740,336. SLNO market cap is 3.81B with 50,393,931 shares outstanding.

.dark-mode .RzdfvL{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .RzdfvL{ color: #333333; background-color: white; border: 2px solid #333333; }SLNOSoleno Therapeutics, Inc. Common Stockstock NASDAQ

SLNO Stock Summary

SLNO
Soleno Therapeutics, Inc. Common Stock
stock NASDAQ